Results 1 to 10 of about 2,107,233 (243)

Transcatheter intervention for doublesteal syndrome from isolation of the subclavian artery associated with patent ductus arteriosus [PDF]

Anatolian Journal of Cardiology, 2020
Bekir Yukcu, Fatma Sevinc Sengul, Alper Guzeltas   +2 more
doaj   +2 more sources

Hemodynamic Changes After Transcatheter Valve Repair and Replacement for Tricuspid Regurgitation [PDF]

Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Background Transcatheter edge‐to‐edge repair (TEER) and replacement (TTVR) have emerged as new modalities to treat patients with symptomatic significant tricuspid regurgitation.
Mohamad S. Alabdaljabar, Mohamed Elhadi, Jeremy J. Thaden, Ratnasari Padang, Sorin V. Pislaru, Benjamin J. Hibbert, Trevor J. Simard, Mohamad A. Alkhouli, Mayra E. Guerrero, Charanjit S. Rihal, Mackram F. Eleid   +10 more
doaj   +2 more sources

Respiratory Trajectory after Invasive Interventions for Patent Ductus Arteriosus of Preterm Infants

Children, 2021
Invasive interventions have been conducted in preterm infants with significant patent ductus arteriosus (PDA) when medical treatment has failed, and methods of invasive intervention have been reported. Surgical ligation via lateral thoracotomy has been a
Yu-Jen Wei, Yen-Ju Chen, Yung-Chieh Lin, Chung-Dann Kan, Min-Ling Hsieh, Yuh-Jyh Lin, Jing-Ming Wu, Jieh-Neng Wang   +7 more
doaj   +1 more source

Transcatheter and surgical aortic valve replacement in patients with left ventricular dysfunction

Journal of Cardiothoracic Surgery, 2022
Background Patients with severe aortic stenosis and left ventricular systolic dysfunction have a poor prognosis, and this may result in inferior survival also after aortic valve replacement.
Maina P. Jalava, Mikko Savontaus, Tuomas Ahvenvaara, Teemu Laakso, Marko Virtanen, Matti Niemelä, Tuomas Tauriainen, Pasi Maaranen, Annastiina Husso, Eve Kinnunen, Sebastian Dahlbacka, Jussi Jaakkola, Stefano Rosato, Paola D’Errigo, Mika Laine, Timo Mäkikallio, Peter Raivio, Markku Eskola, Antti Valtola, Tatu Juvonen, Fausto Biancari, Juhani Airaksinen, Vesa Anttila   +22 more
doaj   +1 more source

Surgical outcomes of patients at prohibitive risk who are reconsidered for surgeryCentral MessagePerspective

JTCVS Open, 2023
Objectives: Transcatheter treatment of advanced mitral and tricuspid valve disease is largely limited to patients at prohibitive surgical risk, although many are not candidates for transcatheter treatment.
Catherine M. Wagner, MD, Megan L. Schultz, MD, Alexander A. Brescia, MD, MSc, Yoyo Wang, BS, Whitney Fu, MD, Robert B. Hawkins, MD, MSc, Matthew A. Romano, MD, Gorav Ailawadi, MD, MBA, Steven F. Bolling, MD   +8 more
doaj   +1 more source

Transcatheter heart valve interventions for patients with rheumatic heart disease

Frontiers in Cardiovascular Medicine, 2023
Rheumatic heart disease [RHD] is the most prevalent cause of valvular heart disease in the world, outstripping degenerative aortic stenosis numbers fourfold.
Hellmuth Weich, Philip Herbst, Francis Smit, Anton Doubell   +3 more
doaj   +1 more source

Simulation to Success

JACC: Case Reports, 2020
Three-dimensional imaging and printed heart models have become increasingly valuable in the management of patients with complex congenital heart disease.
Eimear M. McGovern, MB BCh BAO, Justin T. Tretter, MD, Ryan A. Moore, MD, Bryan H. Goldstein, MD   +3 more
doaj   +1 more source

Outcomes of manually modified microvascular plugs to pulmonary flow restrictors in various congenital heart lesions

Frontiers in Cardiovascular Medicine, 2023
BackgroundThe development of microvascular plugs (MVPs) has enabled novel transcatheter deliverable endoluminal pulmonary flow restrictors (PFRs) with the potential to treat newborns and infants with life-threatening congenital heart diseases (CHDs) in a
Raymond N. Haddad, Jamie Bentham, Ahmed Adel Hassan, Mahmoud Al Soufi, Osama Jaber, Issam El Rassi, Mohamed Kasem   +6 more
doaj   +1 more source

Transcatheter Device Therapy and the Integration of Advanced Imaging in Congenital Heart Disease

Children, 2022
Transcatheter device intervention is now offered as first line therapy for many congenital heart defects (CHD) which were traditionally treated with cardiac surgery.
Abhay A. Divekar, Yousef M. Arar, Stephen Clark, Animesh Tandon, Thomas M. Zellers, Surendranath R. Veeram Reddy   +5 more
doaj   +1 more source

Advances in Transcatheter Electrosurgery for Treating Valvular Heart Disease

US Cardiology Review, 2021
Delivery of electrosurgery energy through catheters and guidewires enables interventionists to ‘cut’ through obstructive intravascular lesions or across cardiac chambers.
Jaffar M Khan, Toby Rogers, Adam B Greenbaum, Vasilis C Babaliaros, John C Lisko, Dursun Korel Yildirim, Christopher G Bruce, Daniel A Herzka, Kanishka Ratnayaka, Robert J Lederman   +9 more
doaj   +1 more source